The SEC settled charges against a medical device manufacturer and its wholly owned subsidiary for engaging in "hundreds of sham transactions with distributors" in violation of the Foreign Corrupt Practices Act.
Global medical device manufacturer Zimmer Biomet Holdings, Inc. settled criminal and civil charges brought by the DOJ and SEC after the company was found to have violated a 2012 agreement settling previous Foreign Corrupt Practices Act allegations.
A Sweden-based telecommunications company agreed to pay $965 million to settle charges of Foreign Corrupt Practices Act violations for alleged bribes of a government official in Uzbekistan. If the criminal plea with the DOJ is approved in U.S. federal court, the combined resolution will mark the largest FCPA settlement ever.
A Canadian gold mining corporation agreed to settle SEC charges that the company failed to maintain adequate internal controls sufficient to prevent and detect illegal payments by two subsidiaries.
A global retailer settled DOJ and SEC charges of violating the books and records and internal accounting controls provision of the Foreign Corrupt Practices Act.